Pfizer hints core drugs unit may be split
The chief’s comments come as it reports a jump in fourth-quarter profits, as proceeds from the sale of its nutrition business offsets lost Lipitor sales
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Atorvastatin Calcium | Lipitor | Nutrition | Pfizer | Pharmaceuticals | Profits and Losses | Statin Therapy | Zivast